Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2018

Jul 11, 2018

32414_dirs_2018-07-11_8dd1f5c3-f9cd-484a-9c02-e3ab76b458ea.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-07-09

Reporting Person: COLLERAN LISA N (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-07-09 Stock Option (right to purchase) $53.65 A 9134 Acquired 2028-07-09 Common Stock (9134) Direct
2018-07-09 Stock Option (right to purchase) $53.65 A 3916 Acquired 2028-07-09 Common Stock (3916) Direct

Footnotes

F1: Option grant for joining the Issuer's Board of Directors. Options vest quarterly as to 12.5% of total share amount beginning with the first vesting date on October 9, 2018 and becoming fully vested July 9, 2020 (two years after grant).

F2: Annual option grant for director of Issuer's Board of Directors, pro-rated for joining Board of Directors during annual period. Option vests quarterly with all shares vested June 1, 2019 in conformity with vesting for such annual director grants.